<bill session="108" type="h" number="896" updated="2013-07-14T19:00:49-04:00">
  <state datetime="2003-02-25">REFERRED</state>
  <status>
    <introduced datetime="2003-02-25"/>
  </status>
  <introduced datetime="2003-02-25"/>
  <titles>
    <title as="introduced" type="short">Breast Cancer Prescription Drug Fairness Act of 2003</title>
    <title as="introduced" type="official">To provide for substantial reductions in the price of prescription drugs for Medicare beneficiaries and for women diagnosed with breast cancer.</title>
  </titles>
  <sponsor id="400257"/>
  <cosponsors>
    <cosponsor id="400001" joined="2003-03-18"/>
    <cosponsor id="400003" joined="2003-02-27"/>
    <cosponsor id="400041" joined="2003-03-13"/>
    <cosponsor id="400047" joined="2003-03-19"/>
    <cosponsor id="400067" joined="2003-03-27"/>
    <cosponsor id="400093" joined="2003-03-18"/>
    <cosponsor id="400111" joined="2003-03-04"/>
    <cosponsor id="400140" joined="2003-03-03"/>
    <cosponsor id="400143" joined="2003-03-03"/>
    <cosponsor id="400179" joined="2003-10-07"/>
    <cosponsor id="400195" joined="2003-03-03"/>
    <cosponsor id="400204" joined="2003-03-06"/>
    <cosponsor id="400216" joined="2003-03-03"/>
    <cosponsor id="400217" joined="2003-02-26"/>
    <cosponsor id="400237" joined="2003-06-03"/>
    <cosponsor id="400266" joined="2003-09-23"/>
    <cosponsor id="400268" joined="2003-02-26"/>
    <cosponsor id="400306" joined="2003-03-03"/>
    <cosponsor id="400312" joined="2003-02-26"/>
    <cosponsor id="400436" joined="2003-03-04"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2003-02-25">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2003-02-25">
      <text>Referred to House Energy and Commerce</text>
    </action>
    <action datetime="2003-02-25">
      <text>Referred to House Ways and Means</text>
    </action>
    <action datetime="2003-03-10">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Energy and Commerce"/>
    </action>
    <action datetime="2003-03-10">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Ways and Means"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
    <committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSWM02" subcommittee="Health" name="House Ways and Means"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Breast cancer"/>
    <term name="Commerce"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Governmental investigations"/>
    <term name="Life expectancy"/>
    <term name="Medicare"/>
    <term name="Pharmacies"/>
    <term name="Prescription pricing"/>
    <term name="Price discrimination"/>
    <term name="Social welfare"/>
    <term name="Terminal care"/>
    <term name="Terminally ill"/>
    <term name="Women"/>
    <term name="Women's health"/>
  </subjects>
  <amendments/>
  <summary>2/25/2003--Introduced.
Breast Cancer Prescription Drug Fairness Act of 2003 - Requires each participating manufacturer of a covered outpatient drug to make available for purchase by each pharmacy a covered outpatient drug: (1) in an amount equal to the aggregate amount of the covered outpatient drug sold or distributed by the pharmacy to Medicare beneficiaries (including the amount sold or distributed to Medicare beneficiaries in a hospice program); and (2) at a price equal to the lower of either the lowest price paid for the drug by the Federal Government or the manufacturer's best price for the drug.</summary>
</bill>
